MTHFR, TS and XRCC1 genetic variants may affect survival in patients with myelodysplastic syndromes treated with supportive care or azacitidine
Visani, G, Loscocco, F, Ruzzo, A, Galimberti, S, Graziano, F, Voso, M T, Giacomini, E, Finelli, C, Ciabatti, E, Fabiani, E, Barulli, S, Volpe, A, Magro, D, Piccaluga, P, Fuligni, F, Vignetti, M, Fazi,Language:
english
Journal:
The Pharmacogenomics Journal
DOI:
10.1038/tpj.2017.48
Date:
December, 2017
File:
PDF, 303 KB
english, 2017